|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| G01N 33/574 | (2006.01) |
| (11) | Number of the document | 3712174 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20159500.6 |
| Date of filing the European patent application | 2014-12-22 | |
| (97) | Date of publication of the European application | 2020-09-23 |
| (45) | Date of publication and mention of the grant of the patent | 2022-03-16 |
| (46) | Date of publication of the claims translation | 2022-05-25 |
| (30) | Number | Date | Country code |
| 201361920695 P | 2013-12-24 | US | |
| 201462085086 P | 2014-11-26 | US |
| (72) |
SNYDER, Linda , US
POWERS, Gordon , US
|
| (73) |
Janssen Pharmaceutica NV ,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (74) |
Stanislava TELEIŠIENĖ,
UAB "Brainera", Taikos 235-17, LT-05213 Vilnius,
LT
|
| (54) | Anti VISTA antikūnai ir fragmentai |
| ANTI-VISTA ANTIBODIES AND FRAGMENTS |
| Payment date | Validity (years) | Amount | |
| 2025-11-24 | 12 | 289.00 EUR |
| 2026-12-22 |